Latest News & Updates
Breaking News
11 hours ago
Simantini Singh Deo
Other trending news you may like to read
AstraZeneca Achieves 43% UPCR Reduction with Ultomiris in Phase III IgA Nephropathy Trial
Ultomiris hits 43.4% UPCR reduction at 34 weeks in Phase III IgA nephropathy trial, signalling a potential new indication filing with FDA and EMA.
Simantini Singh Deo
Eli Lilly Achieves Significant Fat Loss Outcomes in Oral GLP-1 Phase 3 Menopause Subgroup Analysis
Eli Lilly's oral GLP-1 candidate shows fat loss across menopause stages in Phase 3 ATTAIN trials, raising scale-up and formulation questions.
Simantini Singh Deo
Lupin Signs Deal with Laboratorios ERN to Launch Luforbec Inhaler Across Spain
Lupin partners with Laboratorios ERN to commercialise Luforbec in Spain, combining inhaler manufacturing depth with local distribution reach.
Simantini Singh Deo
SPI Pharma Acquires Elementis Pharma, Expanding European Excipient Manufacturing Footprint in Germany
SPI Pharma completes acquisition of Elementis Pharma, adding German GMP manufacturing capacity and specialty excipients for digestive health formulations.
Simantini Singh Deo
